Technical Analysis for ADHD - Alcobra Ltd.

Grade Last Price % Change Price Change
grade D 1.12 1.82% 0.02
ADHD closed up 1.82 percent on Friday, September 22, 2017, on 1.59 times normal volume.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ADHD trend table...

Date Alert Name Type % Chg
Sep 22 Narrow Range Bar Range Contraction 0.00%
Sep 21 50 DMA Support Bullish 1.82%
Sep 21 Doji - Bullish? Reversal 1.82%
Sep 20 Crossed Above 50 DMA Bullish 3.70%
Sep 19 50 DMA Resistance Bearish 5.66%

Older signals for ADHD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of various drugs for the treatment of neurological disturbance. Its principal product includes MG01CI that has completed Phase II studies to treat attention deficit hyperactivity disorder. The company was founded in 2008 and is headquartered in Tel Aviv, Israel.
Is ADHD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.69
52 Week Low 0.83
Average Volume 77,525
200-Day Moving Average 1.2665
50-Day Moving Average 1.0691
20-Day Moving Average 1.0628
10-Day Moving Average 1.1
Average True Range 0.0459
ADX 17.88
+DI 17.46
-DI: 11.11
Chandelier Exit (Long, 3 ATRs) 1.0023
Chandelier Exit (Short, 3 ATRs) 1.1077
Upper Bollinger Band 1.146
Lower Bollinger Band 0.9796
Percent B (%b) 0.84
Bandwidth 0.156568
MACD Line 0.0138
MACD Signal Line 0.0079
MACD Histogram 0.006